Holen Sie sich die Stockscreener-App
3.39
0.88%
-0.03
Handel nachbörslich:
3.40
0.010
+0.29%
Schlusskurs vom Vortag:
$3.42
Offen:
$3.45
24-Stunden-Volumen:
305.49K
Relative Volume:
0.58
Marktkapitalisierung:
$188.48M
Einnahmen:
$163.78M
Nettoeinkommen (Verlust:
$25.88M
KGV:
5.2154
EPS:
0.65
Netto-Cashflow:
$-28.66M
1W Leistung:
-7.88%
1M Leistung:
-15.67%
6M Leistung:
-7.12%
1J Leistung:
-22.60%
1-Tages-Spanne:
$3.36
$3.555
1-Wochen-Bereich:
$3.355
$3.91
52-Wochen-Spanne:
$2.645
$5.55
Voyager Therapeutics Inc Stock (VYGR) Company Profile
Firmenname
Voyager Therapeutics Inc
Sektor
Branche
Telefon
857-259-5340
Adresse
75 HAYDEN AVENUE, LEXINGTON, MA
Compare VYGR vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
3.39 | 190.15M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-02 | Eingeleitet | Citigroup | Buy |
| 2024-11-29 | Fortgesetzt | Wedbush | Outperform |
| 2024-10-16 | Eingeleitet | Leerink Partners | Outperform |
| 2024-03-26 | Eingeleitet | Guggenheim | Buy |
| 2024-03-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-03-07 | Eingeleitet | Citigroup | Buy |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | Eingeleitet | Truist | Buy |
| 2023-03-10 | Eingeleitet | Oppenheimer | Outperform |
| 2021-10-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-02-03 | Herabstufung | Wedbush | Outperform → Neutral |
| 2020-12-24 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-11-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | Eingeleitet | The Benchmark Company | Buy |
| 2020-02-06 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-15 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | Fortgesetzt | BTIG Research | Buy |
| 2018-09-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-12 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-03-12 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-02-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-11-28 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-10-31 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-10-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-10-23 | Bestätigt | Stifel | Buy |
| 2017-10-12 | Eingeleitet | Raymond James | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-28 | Fortgesetzt | Stifel | Buy |
Alle ansehen
Voyager Therapeutics Inc Aktie (VYGR) Neueste Nachrichten
Published on: 2026-02-14 07:15:36 - mfd.ru
Is Voyager Therapeutics Inc. stock a smart retirement pickJuly 2025 Weekly Recap & Consistent Profit Alerts - mfd.ru
What analyst consensus says on Voyager Therapeutics Inc. stockDividend Hike & Target Return Focused Picks - mfd.ru
Is Voyager Therapeutics Inc. subject to activist investor interestWeekly Investment Summary & Daily Chart Pattern Signals - mfd.ru
Voyager Therapeutics Announces Chief Medical Officer Resignation - TipRanks
Todd Alfred Carter Sells 3,525 Shares of Voyager Therapeutics (NASDAQ:VYGR) Stock - MarketBeat
Voyager Therapeutics (NASDAQ:VYGR) COO Sells $17,590.65 in Stock - MarketBeat
Earnings Miss: Can Voyager Therapeutics Inc reach all time highs this year2025 Growth vs Value & AI Powered Market Entry Ideas - baoquankhu1.vn
Alfred Sandrock Sells 12,192 Shares of Voyager Therapeutics (NASDAQ:VYGR) Stock - MarketBeat
What’s the MACD signal for Voyager Therapeutics Inc.2025 Pullback Review & Weekly High Potential Stock Alerts - mfd.ru
Voyager to Present at Upcoming Investor Conferences - markets.businessinsider.com
Biotech Voyager lines up five investor conference talks through March - Stock Titan
FY2030 Earnings Forecast for VYGR Issued By HC Wainwright - MarketBeat
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), InflaRx (IFRX) and Verastem (VSTM) - The Globe and Mail
Can Voyager Therapeutics Inc. continue delivering strong returnsWeekly Stock Recap & Smart Money Movement Tracker - mfd.ru
Weekly Earnings: How does Voyager Therapeutics Inc compare to its peersPortfolio Update Report & Entry Point Confirmation Signals - baoquankhu1.vn
Voyager Therapeutics (NASDAQ:VYGR) Stock Crosses Below Fifty Day Moving AverageWhat's Next? - MarketBeat
Published on: 2026-01-27 16:25:36 - baoquankhu1.vn
Decliners Report: Can Voyager Therapeutics Inc reach all time highs this year - baoquankhu1.vn
Gene Therapy Market Outlook 2026-2031, Featuring Profiles - GlobeNewswire
Gene Therapy Market Outlook 2026-2031, Featuring Profiles of REGENXBIO, Oxford Biomedica, Voyager Therapeutics and More - Yahoo Finance
Stock Market Recap: How does Voyager Therapeutics Inc compare to its peers2025 Trading Volume Trends & Weekly Watchlist of Top Performers - baoquankhu1.vn
Inflation Data: Is Ferroglobe PLC forming a double bottom2025 Biggest Moves & High Return Trade Opportunity Guides - baoquankhu1.vn
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Sentiment Recap: Is Voyager Therapeutics Inc stock a smart retirement pickMarket Volume Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Layoff Tracker: Takeda Slashes US Headcount, Hitting Neuro Commercial Teams Hard - BioSpace
Contrasting Voyager Therapeutics (NASDAQ:VYGR) and Alvotech (NASDAQ:ALVO) - Defense World
Risk Off: Should I buy Voyager Therapeutics Inc stock now2025 Trading Recap & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Voyager Therapeutics Announces Second Quarter 2023 Conference Call and Webcast - IT Business Net
Will Voyager Therapeutics Inc. stock see insider buyingSeasonal Picks & what to check before ordering - ulpravda.ru
How analysts rate Voyager Therapeutics Inc. stock todayWeekly Trend Recap & Expert Verified Movement Alerts - Улправда
Voyager Therapeutics, Inc. Highlights 2026 Milestones and Developments - TradingView — Track All Markets
Published on: 2026-01-08 10:47:34 - Улправда
VOYAGER THERAPEUTICS, INC. (VYGR) - MSN
Voyager Therapeutics (MEX:VYGR) EV-to-OCF : -1.62 (As of Dec. 31, 2025) - GuruFocus
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
What analysts say about Voyager Therapeutics Inc stockGrowth Stock Opportunities & High Return Capital Gain - earlytimes.in
Growth Report: Why Voyager Therapeutics Inc. stock is recommended by analystsPortfolio Performance Report & Technical Pattern Based Buy Signals - Улправда
Why Voyager Therapeutics Inc. stock appeals to analystsEarnings Risk Summary & Fast Moving Trade Plans - Улправда
Voyager Therapeutics (NASDAQ:VYGR) Shares Cross Below Fifty Day Moving AverageTime to Sell? - MarketBeat
With Voyager Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
Why Voyager Therapeutics Inc. stock is recommended by analystsForecast Cut & Low Risk High Reward Ideas - Улправда
Rate Cut: Why Voyager Therapeutics Inc. stock is recommended by analysts2025 Technical Patterns & Growth Focused Entry Reports - Улправда
Is Voyager Therapeutics Inc. stock undervalued vs historical averagesChart Signals & Reliable Breakout Forecasts - Улправда
Movement Recap: Why Voyager Therapeutics Inc. stock is recommended by analystsJuly 2025 Action & AI Optimized Trade Strategies - Улправда
Voyager Throws 30 Staff Overboard After Novartis Sinks Two Programs - BioSpace
How Voyager Therapeutics Inc. stock reacts to oil pricesMarket Movement Recap & Reliable Intraday Trade Alerts - ulpravda.ru
Alzheimer's, ALS, And Huntington's Programs Keep Voyager Therapeutics On Investor Radar - RTTNews
Voyager Therapeutics Earnings Notes - Trefis
Voyager Therapeutics, Inc. $VYGR Shares Sold by Armistice Capital LLC - MarketBeat
Voyager Therapeutics (VYGR): Strong Q3 Prompts Bullish Coverage - Finviz
Finanzdaten der Voyager Therapeutics Inc-Aktie (VYGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Voyager Therapeutics Inc-Aktie (VYGR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sandrock Alfred | President and CEO |
Feb 10 '26 |
Sale |
3.78 |
12,192 |
46,086 |
509,989 |
| Carter Todd Alfred | Chief Scientific Officer |
Feb 10 '26 |
Sale |
3.85 |
3,525 |
13,571 |
153,193 |
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):